Lifecore Biomedical Inc
NASDAQ:LFCR
Lifecore Biomedical Inc
Cash from Financing Activities
Lifecore Biomedical Inc
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Cash from Financing Activities
$20.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-27%
|
CAGR 10-Years
6%
|
|
|
Hershey Co
NYSE:HSY
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
|
|
General Mills Inc
NYSE:GIS
|
Cash from Financing Activities
-$954.4m
|
CAGR 3-Years
34%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-2%
|
|
|
Kellogg Co
NYSE:K
|
Cash from Financing Activities
-$607m
|
CAGR 3-Years
23%
|
CAGR 5-Years
20%
|
CAGR 10-Years
5%
|
|
|
Kraft Heinz Co
NASDAQ:KHC
|
Cash from Financing Activities
-$3B
|
CAGR 3-Years
31%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-5%
|
|
|
Mondelez International Inc
NASDAQ:MDLZ
|
Cash from Financing Activities
-$5.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-8%
|
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
What is Lifecore Biomedical Inc's Cash from Financing Activities?
Cash from Financing Activities
20.6m
USD
Based on the financial report for Nov 24, 2024, Lifecore Biomedical Inc's Cash from Financing Activities amounts to 20.6m USD.
What is Lifecore Biomedical Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
6%
Over the last year, the Cash from Financing Activities growth was -25%.
You don't have any saved screeners yet